Houston, United States
Prana Thoracic is pioneering the future of early intervention in lung cancer, aiming to revolutionize the way this disease is diagnosed and treated. Founded in 2022 in the United States, the company has quickly garnered attention and support in the Health Care industry. With its slogan, "The future of early intervention in lung cancer," Prana Thoracic is dedicated to making impactful strides in the field of cancer care.
The company recently secured a significant $2.21M in Venture Round investment on 18 June 2024, signaling confidence from investors in its mission. This financing round, although the participating investors are not disclosed, reflects the belief in the potential of Prana Thoracic's innovation and its ability to address unmet needs in lung cancer early intervention.
